J&J Wins Patent Fight Over Drug Stent

Law360, New York (April 9, 2007, 12:00 AM EDT) -- A drug-eluting stent distributed by a Johnson & Johnson Inc. subsidiary does not infringe on a Boston Scientific Corp. patent for a method of administering drugs to treat heart disease, a Delaware federal court has ruled.

U.S. District Court Judge Sue Robinson ruled in favor of J&J’s motion for summary judgment of noninfringement on April 4, finding that “based on the evidence of record, no reasonable juror could find for BSC on the issue of infringement,” according to the ruling.

Boston Scientific accused J&J’s Cordis Corp....
To view the full article, register now.